Assignee
PTC THERAPEUTICS INC
US126 patents
Top patents by PatentIndex Score
US7772259B2Aug 10, 2010
1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PTC THERAPEUTICS INC83 citations99
US7419991B2Sep 2, 2008
3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof
PTC THERAPEUTICS INC70 citations99
US7202262B2Apr 10, 2007
Benzoic acid or benzoate substituted 1,2,4-oxadiazole compounds and their use for the treatment of disease
PTC THERAPEUTICS INC111 citations99
US6992096B2Jan 31, 2006
1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PTC THERAPEUTICS INC190 citations99
US7304080B2Dec 4, 2007
Substituted 1,2,4-oxadiazoles, compositions and methods of use
PTC THERAPEUTICS INC55 citations97
US8796322B2Aug 5, 2014
Methods for using 1,2,4-oxadiazole benzoic acid compounds
PTC THERAPEUTICS INC21 citations96
US8017636B2Sep 13, 2011
1,2,4-Oxadiazole benzoic acid compositions and their use in bioassays
PTC THERAPEUTICS INC23 citations96
US7863456B2Jan 4, 2011
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid
PTC THERAPEUTICS INC29 citations96
US7683082B2Mar 23, 2010
1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
PTC THERAPEUTICS INC28 citations96
US9371336B2Jun 21, 2016
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC36 citations94
US9879007B2Jan 30, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC18 citations93
US9617268B2Apr 11, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC32 citations93
US9586955B2Mar 7, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC22 citations93
US9399649B2Jul 26, 2016
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC34 citations93
US9205088B2Dec 8, 2015
Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use
PTC THERAPEUTICS INC13 citations93
US8975287B2Mar 10, 2015
Methods for using 1,2,4-Oxadiazole benzoic acid compounds
PTC THERAPEUTICS INC12 citations93
US9309206B2Apr 12, 2016
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid
PTC THERAPEUTICS INC9 citations92
US7767689B2Aug 3, 2010
Carboline derivatives useful in the treatment of cancer
PTC THERAPEUTICS INC40 citations92
US7678922B2Mar 16, 2010
Processes for the preparation of 1,2,4-oxadiazole benzoic acids
PTC THERAPEUTICS INC31 citations92
US7601840B2Oct 13, 2009
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC39 citations92
US7405233B2Jul 29, 2008
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PTC THERAPEUTICS INC27 citations92
US7927791B2Apr 19, 2011
Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mRNA decay
PTC THERAPEUTICS INC26 citations89
US7291461B2Nov 6, 2007
Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
PTC THERAPEUTICS INC25 citations89
US10874672B2Dec 29, 2020
Methods for treating Huntington's disease
PTC THERAPEUTICS INC13 citations84
US10071081B2Sep 11, 2018
Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use
PTC THERAPEUTICS INC5 citations84
US10028939B2Jul 24, 2018
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
PTC THERAPEUTICS INC3 citations84
US9914722B2Mar 13, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC12 citations84
US9861617B2Jan 9, 2018
Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use
PTC THERAPEUTICS INC4 citations84
US8748625B2Jun 10, 2014
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
PTC THERAPEUTICS INC5 citations84
US10172836B2Jan 8, 2019
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy
PTC THERAPEUTICS INC4 citations83
US10034863B2Jul 31, 2018
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC5 citations83
US9877952B2Jan 30, 2018
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC6 citations83
US9737513B2Aug 22, 2017
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC6 citations83
US9522137B2Dec 20, 2016
Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC8 citations83
US9474743B2Oct 25, 2016
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC8 citations83
US8372860B2Feb 12, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US8367841B2Feb 5, 2013
Processes for the preparation of 1,2,4-oxadiazole benzoic acids
PTC THERAPEUTICS INC10 citations83
US8367694B2Feb 5, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US7781478B2Aug 24, 2010
Methods for treating hepatitis C
PTC THERAPEUTICS INC8 citations83
US7772271B2Aug 10, 2010
Methods for treating hepatitis C
PTC THERAPEUTICS INC8 citations83
US9873677B2Jan 23, 2018
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
PTC THERAPEUTICS INC8 citations82
US7868037B2Jan 11, 2011
Methods for treating hepatitis C
PTC THERAPEUTICS INC18 citations82
US10703701B2Jul 7, 2020
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
PTC THERAPEUTICS INC7 citations81
US8741572B1Jun 3, 2014
Methods of screening for compounds for treating muscular dystrophy using mIGF1 mRNA translation regulation
PTC THERAPEUTICS INC5 citations81
US9394539B1Jul 19, 2016
Survival motor neuron gene (SMN2) mRNA constructs for post-transcription regulation
PTC THERAPEUTICS INC14 citations80
US11174212B2Nov 16, 2021
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC5 citations79
US10517853B2Dec 31, 2019
Methods for treating epilepsy
PTC THERAPEUTICS INC9 citations77
US10959988B2Mar 30, 2021
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
PTC THERAPEUTICS INC1 citations73
US10300047B2May 28, 2019
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
PTC THERAPEUTICS INC1 citations73
US10285980B2May 14, 2019
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC1 citations72
Showing the top 50 of 126 patents by PatentIndex Score.